Browse All

Current Filters

CLEAR FILTER x

TITLE

Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase Three PERSEUS Trial

Author:Fox, Robert   Bar-Or, Amit   Vermersch, Patrick   Oreja Guevara, Celia   Traboulsee, Anthony   Giovannoni, Gavin   Syed, Sana   Sun, Furong   Salloum, Naji   Turner, Timothy   Wallstroem, Erik   Reich, Daniel   

Session Name:PL6: Contemporary Clinical Issues Plenary Session  

Topic:Neurohospitalist  

Program Number:PL6.003  

Author Institution:

Real-world Digital Biomarkers Associated With Their Clinical Counterparts in the MS-DETECT Study

Author:Vermersch, Patrick   Filippi, Massimo   Oreja-Guevara, Celia   Oh, Jiwon   Sejbæk, Tobias   Graves, Jennifer   Klaeylé, Lissandra   Bieuvelet, Séverine   Carment, Loïc   DROUIN, Pierre   Zinaï, Saad   Rufi, Pascal   Padrazzi, Bruno   Ziemssen, Tjalf   

Session Name:P4: Multiple Sclerosis: Digital Health, Biomarkers, and Artificial Intelligence 1  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P4.004  

Author Institution:

Long-term Treatment Effects of Frexalimab on NfL, CXCL13, and Brain Volume Loss in Relapsing Multiple Sclerosis

Author:Granziera, Cristina   Vermersch, Patrick   Djukic, Biljana   Geertsen, Svend S.   Shafer, Andrea T.   Truffinet, Philippe   Giovannoni, Gavin   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P4.009  

Author Institution:

Efficacy and Safety of Frexalimab in Participants With Relapsing Multiple Sclerosis: 3-Year Results From the Phase 2 Open-label Extension

Author:Vermersch, Patrick   Krieger, Stephen   Wiendl, Heinz   Granziera, Cristina   Mao-Draayer, Yang   Cutter, Gary   Kalbus, Oleksandr   Staikov, Ivan   Dufek, Michal   Montalban, Xavier   Saubadu, Stephane   Luo, Xiaodong   Smyth, Brendan   Djukic, Biljana   Truffinet, Philippe   Wallstroem, Erik   Giovannoni, Gavin   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P7.003  

Author Institution:

Subgroup Analyses of the Phase Three Tolebrutinib in Non-relapsing Secondary Progressive Multiple Sclerosis (nrSPMS) HERCULES Trial

Author:Fox, Robert J.   Bar-Or, Amit   Traboulsee, Anthony   Oreja-Guevara, Celia   Giovannoni, Gavin   Vermersch, Patrick   Syed, Sana   Li, Ye   Vargas, Wendy S.   Turner, Timothy J.   Wallstroem, Erik   Reich, Daniel S.   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:General Neurology  

Program Number:P7.004  

Author Institution: